Click to watch the live stream and join the conversation. #PhRMA16

0 SHARES

0

0

0

0

0 SHARES

0

0

0

0

Commitment to Research and Development


Matt Isn't Average


Fighting Rare Diseases


with innovative new medicines

We're Fighting Back


Patients and researchers are working together to fight disease.



The biopharmaceutical industry

continues to be the most R&D-intensive industry in the U.S. economy, and PhRMA member companies are at the forefront. New data show PhRMA member companies invested $58.8 billion in research and development in 2015, up 10.3 percent from 2014.

Learn more



For Cancer Survivors Like Matt, Today is a New Opportunity

Today, with new treatments in the pipeline for cancer, patients and families have more hope than ever before. Learn more about Matt, as he highlights how participation in a clinical trial and innovation from America’s biopharmaceutical research companies has kept him alive.



Medicines in Development for Rare Diseases

More than 560 medicines are in development for rare diseases, including therapies for multiple myeloma, cystic fibrosis and ALS, providing treatment options for patients that had few or no treatment options before.

Learn more



Every Patient Has a Story

At 15 months old, Rhys was unusually tired. His pediatrician quickly figured out why: a tough combination of Type 1 diabetes and Celiac Disease. Fortunately, both can be managed with innovative medicines and diet. Today, Rhys is living the healthy, energetic childhood that every child deserves!

the latest

Get the latest blogs, policy papers, op-eds, and news on patients, innovative medicine development, health care, and more.


  • Dr. George Scangos: Not Just Science for Science’s Sake

    America’s biopharmaceutical researchers and scientists like Dr. George Scangos are working tirelessly to develop new and innovative medicines for patients, particularly neurological diseases, like Alzheimer’s.

    Read more
  • Fighting Skin Diseases

    Biopharmaceutical research companies are developing nearly 300 medicines to treat diseases of the skin.

    Read more
  • Infographic: The Value of Biopharmaceutical Innovation

    America's biopharmaceutical research companies lead the way in improving patient health, advancing medical innovation and fueling economic growth.

    Read more
  • I'm Not Average: Rhys

    Playing and learning all day exhausts most 15 month olds – and their parents. But little Rhys still seemed unusually tired, and his pediatrician discovered why: Type 1 diabetes and Celiac Disease. #ImNotAverage

    Read more
  • Biomarkers and Surrogate Endpoints in Drug Development

    In the age of personalized medicine, biomarkers are emerging as important tools in drug development.

    Read more
  • California

    In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. #Hope2Cures

    Read more

connect with PhRMA...

Make your voice heard. Join the important discussion on the value and economic impact of new medicines.


connect with PhRMA...

Make your voice heard. Join the important discussion on the value and economic impact of new medicines.


  • +68K

    Followers

  • +40K

    Followers

  • 371

    Followers

  • 1424

    Subscribers